- 米国企業
- Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc.NVOS
時価総額
$1348.7万
PER
| 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 8月31日 | 2018年 8月31日 | 2019年 8月31日 | 2020年 8月31日 | 2021年 8月31日 | 2022年 8月31日 | |
| Revenues | - | - | - | - | - | - | 8 | 9 | 9 | 8 | 9 | 12 |
| Cost of revenues | - | - | - | - | - | - | 5 | 5 | 6 | 5 | 5 | 7 |
| Gross profit | - | - | - | - | - | - | 3 | 3 | 4 | 3 | 4 | 5 |
| Selling expenses | - | - | - | - | - | - | 59,026 | 109,295 | 39,931 | 4,921 | 7,525 | 20,702 |
| General and administrative expenses | - | - | - | - | - | - | 3 | 5 | 4 | 7 | 8 | 14 |
| Impairment of assets | - | - | - | - | - | - | - | - | - | - | - | 14 |
| Goodwill impairment | - | - | - | - | - | - | - | - | - | - | - | 1 |
| Total operating expenses | - | - | - | - | - | - | 3 | 5 | 4 | 7 | 8 | 30 |
| Loss from operations | - | - | - | - | - | - | -113,044 | -1,569,428 | -785,597 | -4,262,598 | -4,373,519 | -25,026,677 |
| Interest income | - | - | - | - | - | - | 34,139 | 16,702 | 154,793 | 33,627 | 45,687 | 169,088 |
| Interest expense | - | - | - | - | - | - | - | - | - | - | - | 2 |
| Other income | - | - | - | - | - | - | - | - | - | -194,055 | 21,900 | - |
| Amortization of debt discount | 33,858 | 180,461 | 296,258 | - | - | - | - | - | - | - | - | 6 |
| Foreign currency transaction losses | - | - | - | - | - | - | - | - | - | - | - | -641,643 |
| Total other income (expense) | - | -341,718 | 1 | - | - | - | -520,518 | -547,765 | 382,018 | -661,611 | -97,416 | -8,040,803 |
| Loss before income taxes | - | - | - | - | - | - | -633,562 | -2,117,193 | -403,579 | -4,924,209 | -4,470,935 | -33,067,480 |
| Income tax expense | - | - | - | - | - | - | -111,702 | - | - | - | - | -22,302 |
| Net loss | - | - | - | - | - | - | -745,264 | -2,117,193 | -403,579 | -4,924,209 | -4,470,935 | -33,045,178 |
| Net loss attributed to noncontrolling interest | - | - | - | - | - | - | -6,880 | -9,181 | -11,595 | -9,055 | -8,788 | -195,963 |
| Net loss attributed to Novo Integrated Sciences, Inc. | -2,238,011 | -1,160,250 | -887,672 | -1,033,532 | -2,770,714 | -164,887 | -738,384 | -2,108,012 | -391,984 | -4,915,154 | -4,462,147 | -32,849,215 |
| Foreign currency translation loss | - | - | - | - | - | - | - | -101,029 | -896 | 60,777 | -208,619 | -431,605 |
| Comprehensive loss: | - | - | - | - | - | - | -781,869 | -2,218,222 | -404,475 | -4,863,432 | -4,679,554 | -33,476,783 |
| Net loss per common share - basic and diluted | -0.04 | -0.02 | -0.01 | - | - | - | - | - | - | - | - | -1.13 |